The overall goal of the Imaging Core is to provide unified support for the imaging studies for the Program. This includes technical support for the MRI, MR spectroscopy, PET, and Nuclear Medicine imaging performed as part of the human and animal studies. A second major objective of the imaging core is standardization of the imaging protocols and management of the imaging data. This will facilitate quality control, and will enable consistent imaging protocols to be maintained at the three imaging sites (Duke, NCSU, and CSU). Analysis of the imaging data will also be centralized, with interpretation and quantitative analysis of all imaging data performed at duke. The final goal of the Imaging Core is to provide a forum for interaction among the Project investigators and medical imaging specialists within the Program.
The Specific Aims of the Imaging Core are: 1. Provide technical support and quality assurance for clinical PET studies, including analysis of the 15/O tumor blood flow and oxygenation studies, 2. Provide technical support and quality assurance for MRI and MRS studies, including analysis of the MR spectroscopy and dynamic contrast- enhanced MRI studies, 3.Provide technical support and quality assurance for radiolabeling and imaging liposomes and perform quantitative uptake analysis of the liposomal distribution, 4. Provide clinical radiology expertise for imaging studies, hyperthermia treatment planning, and participation in hyperthermia treatments, 5. Provide general support for MR thermometry and 6. Facilitate transfer and collection of imaging data, and maintain a central database for the imaging results.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
2P01CA042745-14
Application #
6403028
Study Section
Subcommittee E - Prevention &Control (NCI)
Project Start
1987-06-01
Project End
2005-06-30
Budget Start
Budget End
Support Year
14
Fiscal Year
2000
Total Cost
Indirect Cost
Name
Duke University
Department
Type
DUNS #
071723621
City
Durham
State
NC
Country
United States
Zip Code
27705
Stauffer, Paul R; van Rhoon, Gerard C (2016) Overview of bladder heating technology: matching capabilities with clinical requirements. Int J Hyperthermia 32:407-16
Juang, Titania; Stauffer, Paul R; Craciunescu, Oana A et al. (2014) Thermal dosimetry characteristics of deep regional heating of non-muscle invasive bladder cancer. Int J Hyperthermia 30:176-83
Inman, Brant A; Stauffer, Paul R; Craciunescu, Oana A et al. (2014) A pilot clinical trial of intravesical mitomycin-C and external deep pelvic hyperthermia for non-muscle-invasive bladder cancer. Int J Hyperthermia 30:171-5
Angele, Martin K; Albertsmeier, Markus; Prix, Niclas J et al. (2014) Effectiveness of regional hyperthermia with chemotherapy for high-risk retroperitoneal and abdominal soft-tissue sarcoma after complete surgical resection: a subgroup analysis of a randomized phase-III multicenter study. Ann Surg 260:749-54; discussion 754-6
Zagar, Timothy M; Vujaskovic, Zeljko; Formenti, Silvia et al. (2014) Two phase I dose-escalation/pharmacokinetics studies of low temperature liposomal doxorubicin (LTLD) and mild local hyperthermia in heavily pretreated patients with local regionally recurrent breast cancer. Int J Hyperthermia 30:285-94
Viglianti, Benjamin L; Dewhirst, Mark W; Boruta, R J et al. (2014) Systemic anti-tumour effects of local thermally sensitive liposome therapy. Int J Hyperthermia 30:385-92
Cao, Yiting; Eble, Joseph M; Moon, Ejung et al. (2013) Tumor cells upregulate normoxic HIF-1? in response to doxorubicin. Cancer Res 73:6230-42
Boss, M Keara; Muradyan, N; Thrall, D E (2013) DCE-MRI: a review and applications in veterinary oncology. Vet Comp Oncol 11:87-100
Oliveira, Tiago R; Stauffer, Paul R; Lee, Chen-Ting et al. (2013) Magnetic fluid hyperthermia for bladder cancer: a preclinical dosimetry study. Int J Hyperthermia 29:835-44
Dewhirst, Mark W; Landon, Chelsea D; Hofmann, Christina L et al. (2013) Novel approaches to treatment of hepatocellular carcinoma and hepatic metastases using thermal ablation and thermosensitive liposomes. Surg Oncol Clin N Am 22:545-61

Showing the most recent 10 out of 227 publications